1. Drug prices increased twice as quickly than expected during shortage
Manufacturers suspected of exploiting shortage to charge more for drugs in demand
URLs go live when the embargo lifts
Prices for drugs under shortage between 2015 and 2016 increased more than twice as quickly as they were expected to in the absence of a shortage. While researchers could not assess reasons for the increases, manufacturers were suspected of exploiting shortages to charge more for drugs in high demand. A brief research report is published in Annals of Internal Medicine.
Prescription drug shortages cause an estimated $230 million in additional costs each year because of the rising prices of drugs under shortage and the higher costs of substitution drugs. This public health crisis may require attention from policymakers.
Researchers from the University of Pittsburgh School of Pharmacy, UPMC Health Plan and Harvard Medical School used the U.S. Food and Drug Administration (FDA) drug shortages database to identify an active shortage of 917 drugs between December 2015 and December 2016. They then used pricing data from AnalySource to extract monthly wholesale acquisition costs for each drug in the month of the shortage began and the 12 months before and after. In the 11 months after
Article originally posted at